Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Physical training in patients with chronic heart failure: An elaboration of the statements from the Committee on Cardiac Rehabilitation of the Netherlands Society of Cardiology and the Netherlands Heart Foundation and review of studies on physical training in chronic heart failureP J Senden, A Mosterd, J BrügemannDrugs & Aging|August 1, 1997
Pharmacological management of arrhythmias in the elderlyI C Van Gelder, J Brügemann, H J CrijnsDrugs|April 8, 1998
Current treatment recommendations in antiarrhythmic therapyI C Van Gelder, J Brügemann, H J CrijnsNetherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 5, 2015
The diagnosis of left ventricular assist device thrombosisH Z R Gerds, J Brügemann, M Rienstra, et al.Nederlands Tijdschrift Voor Tandheelkunde|March 3, 2006
[Cardiological (pharmaco)therapy and dental practice]J Brügemann, I C van Gelder, J van der Meer, et al.Drugs & Aging|August 1, 1995
Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?J Brügemann, P A de Graeff, J van der Meer, et al.The European Respiratory Journal|November 1, 1995
Thrombolytic therapy of right heart emboli-in-transitG A Jessurun, J Brügemann, J P Hamer, et al.British Heart Journal|December 1, 1990
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarctionJ Brügemann, J van der Meer, B H Takens, et al.Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Cardiac rehabilitation in patients with a congenital heart disease, an implantable cardioverter defibrillator or chronic heart failure]J Brügemann, K Postema, I C van Gelder, et al.The American Journal of Cardiology|June 15, 1990
Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complexB H Takens, J Brügemann, J van der Meer, et al.Pageof 3